← All trials
NCT01810731
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2014
- Primary completion
- Apr 1, 2014
- Completion date
- Apr 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- Kenya Medical Research InstituteOverall official - principal investigator
- Government of KenyaOverall official - principal investigator
- Centers for Disease Control and Prevention (CDC)Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.